- Q1 27
- Q2 23
- Q3 36
- Q4 10
Akademisyen
DİDEM TAŞTEKİN
PROFESÖR
İSTANBUL ÜNİVERSİTESİ ONKOLOJİ ENSTİTÜSÜ KLİNİK ONKOLOJİ ANABİLİM DALI
Araştırma konuları OpenAlex
- Gastric Cancer Management and Outcomes11
- Colorectal Cancer Treatments and Studies11
- Cholangiocarcinoma and Gallbladder Cancer Studies8
- Neuroendocrine Tumor Research Advances7
- Pancreatic and Hepatic Oncology Research7
- Hepatocellular Carcinoma Treatment and Prognosis7
- Thyroid Cancer Diagnosis and Treatment6
- Advanced Breast Cancer Therapies6
- Lung Cancer Treatments and Mutations5
- PARP inhibition in cancer therapy5
- Pancreatitis Pathology and Treatment5
- HER2/EGFR in Cancer Research4
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Akademik özet
YÖKSİS ve OpenAlex ayrı sayılır.
Makale
116
YÖKSİS116
OpenAlex0
Proje
2
Kitap
4
Bildiri
75
Atıf etkisi
OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 26
h-indeks
9
Türkiye yüzdelik dilimi: 85
Üniversitesinde h-indekse göre 79. / 1.015
- i10-indeks
- 9
- Toplam atıf
- 234 Türkiye’de üst %19
- Makale başına
- 9,0
- FWCI
- 0,66 1,00 = dünya ortalaması
- Dünyada üst %1
- 0
- Dünyada üst %10
- 0
En çok atıf alan makaleleri
- Synthesis and Potent Antimicrobial Activity of Some Novel N Alkyl 2 Phenyl 1H Benzimidazole 5 Carboxamidines
- Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology
- Dietary and Demographical Risk Factors for Oesophageal Squamous Cell Carcinoma in the Eastern Anatolian Region of Turkey Where Upper Gastrointestinal Cancers are Endemic
h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.
Alan sıralaması
YÖKSİS ?-
Ana dal Sağlık Bilimleri Temel AlanıPuan sırası #962/ 43.834 üst %2,2Puan 77,75 dergi 77 · OA ek 0,75
- Makale sırası1.505/43.834
- Scopus sırası727/43.834
- WoS sırası737/43.834
- YÖKSİS116
- Scopus96
- WoS95
-
Yan dal Tıbbi Onkoloji (İç Hastalıkları)Puan sırası #28/ 318 üst %8,8Puan 77,75 dergi 77 · OA ek 0,75
- Makale sırası28/318
- Scopus sırası24/318
- WoS sırası25/318
- YÖKSİS116
- Scopus96
- WoS95
Dizin çeyrekleri
?- Q1 7
- Q2 18
- Q3 27
- Q4 44
16 makale
- Üst %1 0
- Üst %10 0
- Ort. 65.4%
- n 51
Diğer sayımlar
Scopus (SJR)
- Özet hariç 95 Q1 26 Q2 23 Q3 36 Q4 10
- YÖKSİS satırı 174
WoS (JCR)
- Özet hariç 94 Q1 6 Q2 18 Q3 27 Q4 44
- En iyi Q 95 Q1 7 Q2 18 Q3 27 Q4 43
- YÖKSİS satırı 169
TR Index
- YÖKSİS satırı 28 makale
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Yayını olan dergiler
63 dergi
- Asian Pacific Journal of Cancer Prevention 9
- Journal of Cancer Research and Therapeutics 9
- Journal of B.U.ON. 8
- Tumor Biology 8
- Clinical Colorectal Cancer 4
- Biomedical Reports 3
- Biomedicine and Pharmacotherapy 3
- 2148-2373 2
- Acta Medica Mediterranea (discontinued) 2
- Alternative Therapies in Health and Medicine (discontinued) 2
- Chinese Journal of Cancer Research 2
- Experimental Oncology 2
- International Journal of Molecular Sciences 2
- Journal of Chemotherapy 2
- Journal of Clinical Oncology 2
- Journal of Oncology Pharmacy Practice 2
- Northern Clinics of Istanbul 2
- Scandinavian Journal of Laboratory Animal Science 2
- Turkish Journal of Medical Sciences 2
- Turk Onkoloji Dergisi 2
- 0042-4870 1
- 0837159 1
- 0975-427X 1
- 1017-6616 1
- 1584-9341 1
- 20201613843 1
- 2020-7115 1
- 2147-0634 1
- 2241-6293 1
- 2300-3235 1
- 2602-3164 1
- 2602-4373 1
- 2618-6454 1
- 2661-4532 1
- 3651-0987 1
- Anti-Cancer Drugs 1
- Arab Journal of Gastroenterology 1
- Cancers 1
- Diagnostics 1
- Eurasian Journal of Medicine and Oncology 1
- European Journal of General Medicine 1
- European Review for Medical and Pharmacological Sciences (discontinued) 1
- International Journal of Clinical and Experimental Medicine (discontinued) 1
- Investigational New Drugs 1
- Journal of Digestive Diseases 1
- Journal of Gastrointestinal Cancer 1
- Journal of Oncological Science 1
- Journal of the College of Physicians and Surgeons Pakistan 1
- Medical Oncology 1
- Medicine (United States) 1
- Melanoma Research 1
- Molecular and Clinical Oncology 1
- Molecules 1
- Oncologist 1
- Oncology Research 1
- Pathology Research and Practice (discontinued) 1
- Revista da Associacao Medica Brasileira 1
- Supportive Care in Cancer 1
- Thoracic Cancer 1
- Tumori 1
- Turkish Journal of Gastroenterology 1
- Turkish Journal of Urology 1
- Wspolczesna Onkologia 1
Makale listesi
- 2025 A Pilot Study of Exploring miRNA–Protein Interaction Networks in Pancreatic Ductal Adenocarcinoma Patients: Implications for Diagnosis and Prognosis YÖKSİS SJR Q2 JCR Q1
- 2025 Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model YÖKSİS SJR Q1 JCR Q2
- 2025 IGF Pathway Components as Potential Biomarkers in Gastric Cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.9%
- 2025 Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model YÖKSİS SJR Q1 JCR Q1
- 2024 The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing YÖKSİS SJR Q3 JCR Q3 OpenAlex 58.4%
- 2024 Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer YÖKSİS SJR Q2 JCR Q2
- 2024 Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma? YÖKSİS
- 2024 Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey. YÖKSİS
- 2024 Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study YÖKSİS SJR Q3 JCR Q2
- 2023 Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.2%
- 2023 Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio YÖKSİS SJR Q1 JCR Q1
- 2023 Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first‑line treatment of metastatic gastric cancer: A single‑center experience YÖKSİS SJR Q3 JCR Q4
- 2023 Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.6%
- 2023 Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye YÖKSİS TR Index SJR Q3 OpenAlex 53.5%
- 2023 Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer YÖKSİS SJR Q3 JCR Q4 OpenAlex 56.6%
- 2022 Capecitabine and temozolomide (CAPTEM) is effective in metastatic well differentiated gastrointestinal neuroendocrine tumors YÖKSİS SJR Q2 JCR Q3
- 2022 Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer YÖKSİS SJR Q3 JCR Q4
- 2022 Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma YÖKSİS SJR Q3 JCR Q4 OpenAlex 51.9%
- 2022 Ibrutinib and panitumumab used in combination safely in a patient with metachronous colorectal cancer and chronic lymphocytic leukemia YÖKSİS SJR Q3 JCR Q3
- 2022 Does nutritional status affect treatment tolerability, chemotherapy response and survival in metastatic gastric cancer patients? Results of a prospective multicenter study in Turkey YÖKSİS SJR Q3 JCR Q4 OpenAlex 65.6%